ScholarLens Back to search
2005•Journal of Clinical UrologyRequires access

Transurethral plasmakinetic vaporization of prostate for treatment of benign prostate hyperplasia (Report of 100 cases)

Dingyi Liu

Open publisher page 0 citations

Abstract

Objective:To assess the safety and efficacy of transurethral plasmakinetic vaporization of prostate (TUPKVP). Methods:100 patients (mean age of 75.5 years,range from 52 to 95) with symptomatic BPH were treated by TUPKVP. Results:All patients were followed up of 3-6 month postoperatively.The peak flow rate increased from 8.2ml/s to 19.5ml/s;The IPSS decreased from 25 to 9,Residual urine volume decreased from 56ml to 10.8ml. Conclusions:It is suggested that TUPKVP is effective,high safetyt and less complications.

About this research paper

What this paper is about

Objective:To assess the safety and efficacy of transurethral plasmakinetic vaporization of prostate (TUPKVP). Methods:100 patients (mean age of 75.5 years,range from 52 to 95) with symptomatic BPH were treated by TUPKVP. Results:All patients were followed up of 3-6 month postoperatively.The peak flow rate increased from 8.2ml/s to 19.5ml/s;The IPSS decreased from 25 to 9,Residual urine volume decreased from 56ml to 10.8ml. Conclusions:It is suggested that TUPKVP is effective,high safetyt and less complications.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To assess the safety and efficacy of transurethral plasmakinetic vaporization of prostate (TUPKVP). Methods:100 patients (mean age of 75.5 years,range from 52 to 95) with symptomatic BPH were treated by TUPKVP. Results:All patients were followed up of 3-6 month postoperatively.The peak flow rate increased from 8.2ml/s to 19.5ml/s;The IPSS decreased from 25 to 9,Residual urine volume decreased from 56ml to 10.8ml. Conclusions:It is suggested that TUPKVP is effective,high safetyt and less complications.

Key concepts: Medicine, Prostate, Urology, Hyperplasia, Vaporization, Urine flow rate, Urinary flow, Urine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Transurethral plasmakinetic vaporization of prostate for treatment of benign prostate hyperplasia (Report of 100 cases) — Research Paper | ScholarLens